Literature DB >> 20195826

Evaluation of plasma carcinogenic markers in rat hepatic tumors models induced by rat hepatoma N1-S1 cells and benzo[a]pyrene.

So-Young Park1, Sohee Phark, Min Lee, Zhi Zheng, Seonyoung Choi, Nam Hee Won, Woon-Won Jung, Donggeun Sul.   

Abstract

Benzo[a]pyrene (BaP) is a known carcinogen. Grilled or smoked meat is the major source of BaP intake for human beings. Previously, we established hepatic tumor animal models by injecting rat hepatoma N1-S1 cells or concomitant injection of N1-S1 cells and BaP into healthy Sprague-Dawley rats. In this study, we performed proteomic analyses of rat plasma collected from a hepatic tumor model and compared them to controls using a 3-10 pI range and large two dimensional gel electrophoreses. Proteomic analyses of rat plasma with hepatic tumors induced by the injection of N1-S1 cells resolved 1295 protein spots. Among them, 10 proteins were identified by ESI-MS-MS; four proteins were up-regulated and six proteins were down-regulated as compared to the controls. In addition, 1295 protein spots were also resolved from rats with hepatic tumors by the injection of N1-S1 cells plus BaP; five proteins were upregulated, and seven proteins were down-regulated. Of these 12 proteins, 10 proteins were identified by ESI-MS-MS. Out of 20 identified proteins, alpha-1-inhibitor 3 and zero beta-1 globin were down-regulated in both rats with hepatic tumors by N1-S1 cell-only and rats with hepatic tumors by the injection of N1-S1 cell plus BaP as compared to the controls. In addition, the identities of four proteins, including dermcidin, serum amyloid P-component (SAP), proteasome subunit alpha type-4 and glutathione peroxidase 3 (GPX-3) were confirmed by western blot analysis. Therefore, the importance of those proteins as candidate biomarkers for the development of hepatic tumors should be further elucidated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195826     DOI: 10.1007/s12272-010-0210-9

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Proteomics approaches for identification of tumor relevant protein targets in pulmonary squamous cell carcinoma by 2D-DIGE-MS.

Authors:  Hao Lihong; Gong Linlin; Guo Yiping; Song Yang; Qi Xiaoyu; Guan Zhuzhu; Yang Xiaohan; Zhou Xin; Xue Liyan; Shao Shujuan
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

2.  Binding of Y-P30 to syndecan 2/3 regulates the nuclear localization of CASK.

Authors:  Peter Landgraf; Marina Mikhaylova; Tamar Macharadze; Corinna Borutzki; Ana-Claudia Zenclussen; Petra Wahle; Michael R Kreutz
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

3.  Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.

Authors:  Jung-Mo Ahn; Hye-Jin Sung; Yeon-Hee Yoon; Byung-Gyu Kim; Won Suk Yang; Cheolju Lee; Hae-Min Park; Bum-Jin Kim; Byung-Gee Kim; Soo-Youn Lee; Hyun-Joo An; Je-Yoel Cho
Journal:  Mol Cell Proteomics       Date:  2013-10-01       Impact factor: 5.911

4.  Analysis of Y-P30/Dermcidin expression and properties of the Y-P30 peptide.

Authors:  Marina Mikhaylova; Anne Schumacher; Corinna Borutzki; Janine R Neumann; Tamar Macharadze; Tarek El-Mousleh; Petra Wahle; Ana C Zenclussen; Michael R Kreutz
Journal:  BMC Res Notes       Date:  2014-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.